The comprehensive findings of this study underscore the proficient accomplishment of non-viral miRNA delivery using the novel ELP-based Tat-A86 nanoparticles, thereby unveiling prospective applications in precision-targeted cancer therapeutics. Here, TAT is linked to cancer.